Morgan Stanley »

Bright Minds Biosciences shares owned by Morgan Stanley

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $4.2M 162k 26.11
2024-12-31 $6.0M 168k 36.02

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Commodore Capital
Perceptive Advisors
Adage Capital Partners GP
Braidwell
BlackRock
Sio Capital Management
Balyasny Asset Management
Morgan Stanley
Point72 Asset Management
Longwood Capital Partners
Millennium Management
Walleye Trading Advisors

View all funds holding Bright Minds Biosciences